Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3487411011 | Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3677808015 | Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4558181000052113 | elvitegravir 150 milligram, emtricitabin 200 milligram, kobicistat 150 milligram och tenofoviralafenamid 10 milligram, oral tablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Is a | Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | false | Inferred relationship | Some | ||
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 5 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 5 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 5 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 6 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 6 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 6 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 7 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 7 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 7 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has active ingredient | Cobicistat | false | Inferred relationship | Some | 8 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has basis of strength substance (attribute) | Cobicistat | false | Inferred relationship | Some | 8 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har täljarvärde som visar styrka | 150 (qualifier value) | false | Inferred relationship | Some | 8 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 8 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 8 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 8 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has active ingredient | Elvitegravir (substance) | false | Inferred relationship | Some | 6 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has basis of strength substance (attribute) | Elvitegravir (substance) | false | Inferred relationship | Some | 6 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har täljarvärde som visar styrka | 150 (qualifier value) | false | Inferred relationship | Some | 6 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has active ingredient | Emtricitabine (substance) | false | Inferred relationship | Some | 7 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has basis of strength substance (attribute) | Emtricitabine (substance) | false | Inferred relationship | Some | 7 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har täljarvärde som visar styrka | 200 (qualifier value) | false | Inferred relationship | Some | 7 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has active ingredient | Tenofovir alafenamide (substance) | false | Inferred relationship | Some | 5 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has basis of strength substance (attribute) | Tenofovir alafenamide (substance) | false | Inferred relationship | Some | 5 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har täljarvärde som visar styrka | 10 (qualifier value) | false | Inferred relationship | Some | 5 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 4 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har täljarvärde som visar styrka | 150 (qualifier value) | false | Inferred relationship | Some | 2 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 3 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 4 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har täljarvärde som visar styrka | 150 (qualifier value) | false | Inferred relationship | Some | 1 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 4 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has basis of strength substance (attribute) | Cobicistat | false | Inferred relationship | Some | 1 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has precise active ingredient | Cobicistat | false | Inferred relationship | Some | 1 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has basis of strength substance (attribute) | Emtricitabine (substance) | false | Inferred relationship | Some | 3 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har täljarvärde som visar styrka | 200 (qualifier value) | false | Inferred relationship | Some | 3 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has precise active ingredient | Elvitegravir (substance) | true | Inferred relationship | Some | 2 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has basis of strength substance (attribute) | Elvitegravir (substance) | true | Inferred relationship | Some | 2 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has precise active ingredient | Emtricitabine (substance) | false | Inferred relationship | Some | 3 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | har täljarvärde som visar styrka | 10 (qualifier value) | false | Inferred relationship | Some | 4 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has precise active ingredient | Tenofovir alafenamide (substance) | true | Inferred relationship | Some | 4 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has basis of strength substance (attribute) | Tenofovir alafenamide (substance) | true | Inferred relationship | Some | 4 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | räkning av bas i aktiv ingrediens | 4 (qualifier value) | false | Inferred relationship | Some | ||
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Is a | Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has basis of strength substance (attribute) | Cobicistat | true | Inferred relationship | Some | 3 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has basis of strength substance (attribute) | Emtricitabine (substance) | true | Inferred relationship | Some | 1 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has precise active ingredient | Emtricitabine (substance) | true | Inferred relationship | Some | 1 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Has precise active ingredient | Cobicistat | true | Inferred relationship | Some | 3 | |
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Is a | Cobicistat-containing product in oral dose form | false | Inferred relationship | Some | ||
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Is a | Elvitegravir-containing product in oral dose form | false | Inferred relationship | Some | ||
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet | Is a | Emtricitabine-containing product in oral dose form | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets